Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biosimilars
Sort By
Newest First
1 / 4
1 / 4
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07
July 16, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06
July 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09
July 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10
July 16, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09
March 13, 2024
Biotherapeutics
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
John R. Mosack
Tanvex CDMO
PAO-10-23-CL-05
November 07, 2023
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-01
March 07, 2023
Life Science Industrials
Filling Industry Gaps and Driving Innovation with Life Science Industrials
Reinhard Vogt; Sebastien Latapie
Dynamk Capital
PAO-11-21-CL-01
November 03, 2021
Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra®
Biogen
PR-M06-21-010
June 08, 2021
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Mark Woolf
Catalent
PAO-03-21-CL-06
March 22, 2021
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
Richard Richieri
Avid Bioservices
PAO-03-21-CL-03
March 18, 2021
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018
September 29, 2020
The Future of Healthcare
How Is Polpharma Biologics Evolving its Business Model to Meet the Future of Healthcare?
Polpharma Biologics
PAP-Q3-20-RT2-007
September 29, 2020
The Future of Healthcare
How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare?
Polpharma Biologics
PAP-Q2-20-RT2-004
July 01, 2020
Biosimilar
iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar
About iBio, Inc.
PR-M04-20-NI-014
April 08, 2020
BLA
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review
Biocon and Mylan Partnership
PR-M03-20-NI-014
March 10, 2020
Biosimilars
FDA Statement on Low-Cost Biosimilar and Interchangeable Protein Products
FDA
PR-M12-19-NI-037
December 20, 2019
Biosimilars
Numerous Biosimilar Launches Coming Soon in United States
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M12-19-NI-007
December 13, 2019
FDA Approval
Sandoz Receives FDA Approval for Oncology Supportive Care Biosimilar Ziextenzo™
Sandoz
PR-M11-19-NI-006
November 08, 2019
Biosimilars
Is the U.S. Biosimilars Market Poised for Takeoff?
Haig Armaghanian
Haig Barrett
PAP-Q3-19-CL-015
October 28, 2019
